Clinical Trial Update: A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone [Phase 3]

View source ↗

Summary

This clinical trial update describes a randomized, placebo-controlled, crossover Phase 3 study evaluating low-dose naltrexone in individuals with multiple scler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED